Your session is about to expire
← Back to Search
Pre-operative Enoxaparin for Blood Clots
Study Summary
This trial is testing whether it's better to give a blood-thinning drug before or after surgery to people with orthopedic injuries.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have bleeding inside your brain.You have chronic kidney disease that needs dialysis, or your kidney function is not normal, which means you need a lower dose of Enoxaparin.You have had a blood clot in your legs before starting the study drug.You are older than 18 years.You recently had a serious injury to your long bones or pelvis that needed surgery.
- Group 1: Enoxaparin
- Group 2: Placebo dose given and Enoxaparin dose held
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Enoxaparin received authorization from the FDA?
"Having already been approved, Enoxaparin received a safety rating of 3 out of the possible maximum score."
What is the main focus of this clinical investigation?
"The primary objective of this clinical trial, which will be evaluated over a 24 hour period post-surgery, is to explore the risk for bleeding complications related to deep vein thrombosis (DVT) chemoprophylaxis. Secondary aims involve assessing the feasibility of launching a larger study by gauging its design and duration as well as recording any incidence of DVT or pulmonary embolism."
How many individuals are partaking in this clinical research endeavor?
"Affirmative, according to clinicaltrials.gov this research endeavour is still seeking participants. It was initially uploaded on December 16th 2019 and the most recent update occurred October 21st 2022 - 60 individuals are needed across a single medical centre."
What maladies is Enoxaparin typically prescribed to address?
"Enoxaparin is a highly versatile medication, primarily used to treat diarrhea but also useful for general surgical procedures, urine alkalinization therapy, and sodium depletion."
Has Enoxaparin been researched in any other scientific experiments?
"As of now, 119 studies exploring Enoxaparin are in progress with 31 trials currently at Phase 3. Out of the 747 locations worldwide running these tests, several can be found in Calgary, Alberta."
Are there opportunities for enrolment in this trial?
"Affirmative. The clinical trial is actively recruiting as attested to by the information on clinicaltrials.gov; it was first made available on December 16th 2019 and amended most recently on October 21st 2022. 60 participants are needed from just one medical centre for this study."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger